Feyma Timothy, Carter Gregory T, Weiss Michael D
Department of Neurology, University of Washington Medical Center, 1959 NE Pacific Street, Seattle, WA 98195, USA.
Muscle Nerve. 2008 Jul;38(1):916-20. doi: 10.1002/mus.21046.
Myotonic dystrophy type 1 (DM1) is an autosomal-dominant multisystemic disorder that may rarely be associated with benign and malignant neoplasms. Cases of both thymoma and myasthenia gravis in association with DM1 are extremely rare. A literature review revealed only three prior reports. We present a 51-year-old man with a family history of DM1 and fluctuating diplopia and ptosis, who was found to have acetylcholine receptor-binding antibodies, thymoma, and a clinical presentation compatible with ocular myasthenia gravis as well as positive genetic testing for DM1. Needle electromyographic (EMG) study demonstrated diffuse runs of myotonic discharges in multiple muscles, consistent with the diagnosis of DM1. Single-fiber EMG showed both increased jitter and blocking. Due to somatic instability, which has been shown previously in DM1, the myotonin protein kinase (DMPK) gene appears to act as a tumor suppressor. Therefore, abnormal CTG repeat expansions in the gene could lead to the development of thymoma and myasthenia gravis.
1型强直性肌营养不良(DM1)是一种常染色体显性多系统疾病,很少与良性和恶性肿瘤相关。胸腺瘤和重症肌无力与DM1相关的病例极为罕见。文献综述仅发现三篇既往报告。我们报告一名51岁男性,有DM1家族史,伴有波动性复视和上睑下垂,发现其有乙酰胆碱受体结合抗体、胸腺瘤,临床表现符合眼肌型重症肌无力,且DM1基因检测呈阳性。针极肌电图(EMG)研究显示多块肌肉出现弥漫性强直性放电,符合DM1的诊断。单纤维EMG显示抖动增加和阻滞。由于DM1先前已显示出体细胞不稳定性,肌强直性蛋白激酶(DMPK)基因似乎起到肿瘤抑制作用。因此,该基因中异常的CTG重复扩增可能导致胸腺瘤和重症肌无力的发生。